{"disease":{"id":"opioid-withdrawal","name":"Opioid withdrawal","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"methadone","indication_name":"Opioid withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Methadone Hydrochloride","generic_name":"METHADONE","company_name":"Specgx Llc","drug_phase":"marketed","molecular_target":"mu-opioid receptors, NMDA receptor","drug_class":"Opioid Agonist","quality_score":66,"revenue":null,"mechanism":"Methadone is a synthetic opioid that acts as a mu-agonist, providing analgesia and aiding in opioid addiction management."},{"drug_id":"lofexidine","indication_name":"Opioid withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lucemyra","generic_name":"LOFEXIDINE","company_name":"Biocorrx Pharms","drug_phase":"marketed","molecular_target":"Alpha-2A adrenergic receptor","drug_class":"lofexidine","quality_score":null,"revenue":null,"mechanism":"Lucemyra works by activating the alpha-2A adrenergic receptor to reduce the release of norepinephrine, a neurotransmitter involved in withdrawal symptoms."},{"drug_id":"methadon","indication_name":"Opioid withdrawal","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Methadon","company_name":"University of Utah","drug_phase":"discontinued","molecular_target":"Neuronal acetylcholine receptor subunit alpha-10, D(4) dopamine receptor, D(3) dopamine receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07466784","title":"CEDRN: Opioid Registry","phase":"","overall_status":"RECRUITING","enrollment_count":7200,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT07278375","title":"Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":796,"lead_sponsor_name":"HELP for NOWS Consortium","has_results":false},{"nct_id":"NCT06442566","title":"ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT04470050","title":"Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT04080037","title":"Assessing Opioid Care Practices Using CPV Patient Simulation Modules","phase":"NA","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Qure Healthcare, LLC","has_results":false},{"nct_id":"NCT04850664","title":"Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":190,"lead_sponsor_name":"Evon Medics LLC","has_results":false},{"nct_id":"NCT04214834","title":"Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":189,"lead_sponsor_name":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program","has_results":true},{"nct_id":"NCT05712707","title":"Sublingual Dexmedetomidine for Treating Opioid Withdrawal","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"New York State Psychiatric Institute","has_results":false},{"nct_id":"NCT03918850","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT03485430","title":"Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Lund University Hospital","has_results":false},{"nct_id":"NCT03971097","title":"The Effect of Self-Forgiveness on Self-Stigma in Addiction.","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT04834297","title":"Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT04140955","title":"Opioid Tapering After Spine Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT05053503","title":"Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Spark Biomedical, Inc.","has_results":false},{"nct_id":"NCT05511909","title":"Evaluating Buspirone to Treat Opioid Withdrawal","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03911466","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT04218240","title":"Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT03789214","title":"Medical Management of Sleep Disturbance During Opioid Tapering","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT04049799","title":"Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions","phase":"","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"University of Vermont","has_results":false},{"nct_id":"NCT04759703","title":"Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":75,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT03911739","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":71,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT05027919","title":"Assessing a Clinically-meaningful Opioid Withdrawal Phenotype","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT05555485","title":"Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"The University of Texas Medical Branch, Galveston","has_results":false},{"nct_id":"NCT05129020","title":"Neurostimulation to Improve NOWS Outcomes","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Spark Biomedical, Inc.","has_results":false},{"nct_id":"NCT05937594","title":"MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT04325659","title":"An Innovative Intervention for OUD Treatment","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT05746507","title":"Night Respite for Postpartum Mothers With SUD","phase":"NA","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT05790252","title":"Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT04075214","title":"Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Spark Biomedical, Inc.","has_results":false},{"nct_id":"NCT07079215","title":"Evaluation of a Physical Device for Medical Use (ADTPM 1) for Opioid Withdrawal Symptoms","phase":"NA","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Nu Eyne Co., Ltd.","has_results":false},{"nct_id":"NCT06487533","title":"Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Spark Biomedical, Inc.","has_results":false},{"nct_id":"NCT05307458","title":"Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"United Health Services Hospitals, Inc.","has_results":false},{"nct_id":"NCT03521960","title":"Buspirone for Opioid Tapering","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT04298853","title":"Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT04162145","title":"BRIDGE Device for Treatment of Opioid Withdrawal","phase":"NA","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"BrightView LLC","has_results":false},{"nct_id":"NCT04104646","title":"CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":true},{"nct_id":"NCT04126083","title":"Lofexidine for Adults Undergoing Lumbar Spine Surgery","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT04731935","title":"Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal","phase":"NA","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Spark Biomedical, Inc.","has_results":false},{"nct_id":"NCT04070157","title":"Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"USWM, LLC (dba US WorldMeds)","has_results":true},{"nct_id":"NCT04238754","title":"Oral Cannabidiol for Opioid Withdrawal","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Johns Hopkins University","has_results":true},{"nct_id":"NCT03489161","title":"Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT04455802","title":"Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Women and Infants Hospital of Rhode Island","has_results":false},{"nct_id":"NCT05790551","title":"Suboxone Dispenser for OUD","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Addinex Technologies, Inc.","has_results":false}],"total":43},"guidelines":[],"source":"Drug Landscape verified database"}